25-27 октября в Милане пройдет 16-я Европейская конференция по СПИДу

We have the pleasure to welcome you to Milan, the Italian capital of fashion and business. It is a vibrant city where history meets with modernity and constitutes one of the main Italy’s centres of science and medicine. It is a magnetic point for designers, artists, photographers and is renowned for its arts and culture. The MiCo – Milano Congressi – not only will serve as a top-quality, modern congress venue, but it is also located in the centre of the city.

Since the last time EACS was organised in Milan 27 years ago, HIV has undergone major and significant changes with the “normalisation” of HIV infection with a life expectancy approaching that of general population, reduced transmission and universal antiretroviral therapy from diagnosis. However, there are still many challenges and this conference will address many of these issues including: long-term effectiveness of drugs, co-infections with TB or viral hepatitis and other co-morbidities, and most importantly inequitable access to care across Europe. We also face many new emerging challenges in Europe, with increasing migration, disruption of healthcare services and drug supply chains, gender issues, and the need to implement widespread community testing and pre-exposure prophylaxis strategies.

As a special feature, we are happy that the 18th International Workshop on Co-morbidities & Adverse Drug Reactions in HIV is affiliated with this EACS Conference to stimulate synergies in addressing issues concerning long-term care which are of common interest.

EACS 2017 promises to offer an exciting scientific programme, composed of state-of-the-art plenary lectures, including Meet the Expert and abstract- driven sessions presenting the latest research in the field of HIV medicine. The Conference will, as usual, provide the platform to present the bi-annual review of the EACS Guidelines. Furthermore, in line with EACS educational goals, it hopes to provide an opportunity for younger investigators to actively participate and present their research. To this end, as before, we are pleased to offer a number of scholarships to applicants from Europe and beyond.